Revenue segments as reported by the company.

Health and Wellness

Household

Lifestyle

International

Corporate

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling and administrative

Advertising

Research and development

Goodwill, trademark and other asset impairments

Interest expense

Other (income) expense, net

Pension settlement charge

Loss on divestiture

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clorox

Brita GmbH is a German company that specializes in water filters. The company headquarters are in Taunusstein near Wiesbaden in Hesse, Germany with production facilities in Germany, Switzerland, the United Kingdom, Italy and China. Brita products are distributed in 66 countries.

Brita

Lestoil is a registered trade name of Clorox for a heavy-duty multi-purpose cleanser product, used to remove extremely difficult laundry stains, dissolve water-based and oil-based paints, and clean grease, oil, paint, and adhesives from floors and surfaces.

Lestoil

Burt's Bees  is an American personal care products company that markets its products internationally. The company is a subsidiary of Clorox making products for personal care, health, beauty, and personal hygiene. As of 2007, they manufactured over 197 products for facial and body skin care, lip care, hair care, baby care, men's grooming, and outdoor remedies. Since then, their products have been distributed in nearly 30,000 retail outlets including grocery stores and drug store chains globally.

Burt's Bees

The Clorox Company (formerly Clorox Chemical Co.), based in Oakland, California, is an American worldwide manufacturer and marketer of consumer and professional products with approximately 8,100 employees worldwide as of June 30, 2017. The company’s fiscal year 2017 net sales were $6.0 billion, which ranked the company at #453 on Fortune’s 2017 Fortune 500 list.

Pine-Sol is a registered trade name of Clorox for a line of household cleaning products, used to clean grease and heavy soil stains. Pine-Sol was based on pine oil when it was created in 1929 and during its rise to national popularity in the 1950s. However, as of 2016, Pine-Sol products sold in stores no longer contain pine oil as a result of the increased cost of the commodity.

Pine-Sol

Formula 409 is a brand of home & Industrial cleaning products well known in North America, but virtually unknown in other countries. It includes Formula 409 All-Purpose Cleaner, Formula 409 Glass and Surface Cleaner, Formula 409 Carpet Cleaner, and many others. The brand is currently owned by Clorox.

Formula 409

Kingsford is a brand of charcoal used for grilling, along with related products. The brand is owned by The Clorox Company. Currently, the Kingsford Products Company remains the leading manufacturer of charcoal in the US, enjoying 80 percent market share. More than 1 million tons of wood scraps are converted into charcoal briquets annually

Kingsford

Liquid-Plumr is a chemical drain opener made of 0.5–2% sodium hydroxide and 5–10% sodium hypochlorite, and a surfactant, produced by Clorox. The product is safe for septic systems, PVC, plastic, and copper pipes, although is not recommended for and can damage rubber piping.

Liquid-Plumr

The Glad Products Comapny is an American company specializing in trash bags and plastic food storage containers. In 2002, Clorox allowed Procter & Gamble to buy a 10% share in Glad Products Company, thus making it a joint venture. Three years later, P&G exercised its option under the agreement to increase its ownership to 20%, the maximum allowed under the joint venture agreement.

The Glad Products Comapny

The Clorox Co. engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States. The Household segments consists of bags and wraps, grilling products and cat litter marketed and sold in the United States. The Lifestyle segment refers to food, natural personal care products and water-filtration products marketed and sold in the United States. The International segment covers products sold outside the United States, excluding natural personal care products. The company was founded by Edward Hughes, Charles Husband, William Hussey, Rufus Myers, and Archibald Taft on May 3, 1913 and is headquartered in Oakland, CA.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

CLX reports strong Q3 results amidst macro uncertainty and digital transformation

CLX delivered strong Q3 results amidst ongoing macro uncertainty and inflationary headwinds. The company aims to balance top-line growth and margin rebuilding, while strategically addressing challenges in the promotional environment. Opportunities lie in potential business sales and ongoing digital transformation.

Clorox surpasses Q2 expectations, focuses on margin rebuilding strategies

Clorox's Q2 performance exceeded expectations, showcasing resilience and strategic focus amidst challenges in certain business segments.
The company's emphasis on rebuilding margins through pricing, cost savings, and strategic investments positions it well for future growth and recovery.
With a strong brand portfolio and a focus on innovation and operational optimization, Clorox is navigating a volatile operating environment with a long-term growth perspective.

Clorox reports robust Q3 earnings, focuses on marketing ROI

Clorox's strong Q3 performance, focus on marketing ROI, and investments in digital transformation position the company for growth. Challenges include inflationary pressures and the need to balance growth with margin improvement. Opportunities exist in rebuilding margins, strategic promotions, and continued investment in advertising and innovation.

Clorox reports robust FY 2023 results, eyes innovation amid challenges

Clorox's strong fiscal year 2023 performance sets the stage for navigating challenges like cost inflation and a potential recession in fiscal year '24. By focusing on innovation, advertising, and operational efficiency, Clorox aims to drive growth and rebuild margins. The company's strategic priorities for fiscal year '24 include enhancing value, driving top-line growth, and managing cost pressures.

Clorox faces cyber attack fallout, focuses on recovery and innovation

Clorox navigates post-cyber attack challenges with a focus on recovery, innovation, and consumer trust rebuilding. Strong brand trust and cost-saving initiatives support the company's resilience. Opportunities for growth exist in digital transformation, innovation, and strategic partnerships.

Clorox surpasses Q2 expectations post-cyber attack, eyes growth strategies

Clorox's strong Q2 performance post-cyber attack showcases resilience and strategic focus. Challenges include FX headwinds and consumer pressure, but opportunities lie in pricing strategies and volume-driven growth. Company remains confident in brand portfolio and operational improvements.

Clorox exceeds EPS expectations, faces supply chain challenges

Clorox's Q3 performance saw mixed results with strong EPS but lower sales.
Facing challenges in supply chain recovery and market share restoration.
Opportunities lie in innovation, cost savings, and stable growth regions.
Confidence in exceeding gross margin targets and meeting EPS guidance.

Clorox reports resilient performance and strategic growth plans for FY 2025

Clorox's FY 2024 performance showcased flat organic sales but sustained margin expansion, setting the stage for double-digit EPS growth in FY 2025.
The company's strategic focus on brand resilience, innovation, and marketing, alongside digital transformation, positions them for growth and market share recapture.
Challenges in the household business and external factors like cyber attacks and inflation necessitate adaptive strategies while pursuing margin restoration and growth.
Opportunities lie in portfolio reshaping, segment outperformance, and market agility, driving Clorox towards sustained profitability and shareholder value enhancement.

Clorox reports robust Q1 performance, eyes sustained growth opportunities

Clorox's Q1 2025 showcased strong performance with market share gains and gross margin expansion, underpinned by strategic investments.
While facing challenges in market dynamics and promotional environments, the company remains focused on delivering value and innovation.
Opportunities for growth lie in sustained international performance, brand investment, and navigating evolving market conditions.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

AbbVie

Abbott Labs

Automatic Data Processing

Aflac

Cigna

Colgate-Palmolive

Cisco Systems

Emerson Electric

Intel

Illinois Tool Works

Johnson & Johnson

Lockheed Martin

Medtronic

Microsoft

QUALCOMM

Rio Tinto plc Sponsored

AT&T

UnitedHealth Group

Walgreens

Waste Management

Walmart

We present the 2022 year-end review of our eight-year-old Passive DGI-Core Portfolio. We consider this portfolio and strategy as the foundation of our overall portfolio. We will provide updates on changes, additional investments, dividends collected, and an overall 2022 performance.

The 4% DGI Core Portfolio: 2022 Year-End Review

Ecolab

Essex Property Trust

W.W. Grainger

Lowe's

McCormick

Realty Income Corp

PPG Industries

Sherwin-Williams

Stanley Black & Decker

Sysco

T. Rowe Price Group

V.F.

West Pharmaceutical Services

NOBL fell 4.12% in December, which brings the Fund's return for the year to a loss of 6.5%. Thus far this month, through January 25th, the dividend aristocrat ETF is up 1.92% and starting the year on a bright note.

My Best Dividend Aristocrats For February 2023

Tyson Foods

The boom in the technology industry came to an end in 2022. Pandemic-driven demand started to reverse.

3 Consumer Staples Stocks That Will Be Big Winners in 2023

Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Clorox (CLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

A company increasing its dividend in each of the past 20 years is no small task, especially given that the period includes the Great Financial Crisis and the COVID-19 meltdown. Entities that have been paying dividends have experienced resilient performance during the past 12-18 months, and this will likely continue in the coming quarters.

Three 3%+ Yielders With 20 Consecutive Years Of Dividend Growth

A. O. Smith

Air Products and Chemicals

Franklin Resources

Cardinal Health

Caterpillar

Cincinnati Financial

Cintas Corp

Chevron

Expeditors International of Washington

General Dynamics

Genuine Parts

Hormel Foods

Kimberly-Clark

Coca-Cola

New Linde PLC

I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process and comparing the results to NOBL and SCHD.

Selecting Dividend Aristocrats Using SCHD Methodology - Slow And Steady

Archer-Daniels-Midland Company

Albemarle

Amcor Plc

Atmos Energy

Becton, Dickinson and Co.

Brown & Brown

Chubb

Church & Dwight

Dover

Investors looking for stability and payout growth should look closer at Dividend Aristocrat stocks.

S&P 500's Best Dividend Aristocrats

News for Clorox Stock (CLX)